|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
¶ – Release Delayed ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 9/23/13 Biocept Inc S-1¶ 71:6.2M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-1 Registration Statement (General Form) HTML 1.65M 71: COVER ¶ Comment-Response or Cover Letter to the SEC HTML 85K 2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 77K 3: EX-3.1.1 Articles of Incorporation/Organization or By-Laws HTML 28K 4: EX-3.1.2 Articles of Incorporation/Organization or By-Laws HTML 27K 5: EX-3.1.3 Articles of Incorporation/Organization or By-Laws HTML 35K 6: EX-3.2 Articles of Incorporation/Organization or By-Laws HTML 150K 7: EX-3.2.1 Articles of Incorporation/Organization or By-Laws HTML 86K 8: EX-10.1 Material Contract HTML 130K 9: EX-10.1.1 Material Contract HTML 69K 10: EX-10.1.2 Material Contract HTML 52K 23: EX-10.10 Material Contract HTML 27K 24: EX-10.11 Material Contract HTML 192K 25: EX-10.11.1 Material Contract HTML 100K 26: EX-10.11.2 Material Contract HTML 32K 27: EX-10.11.3 Material Contract HTML 57K 28: EX-10.11.4 Material Contract HTML 30K 29: EX-10.11.5 Material Contract HTML 37K 30: EX-10.11.6 Material Contract HTML 60K 31: EX-10.12 Material Contract HTML 89K 32: EX-10.13 Material Contract HTML 130K 33: EX-10.14 Material Contract HTML 111K 34: EX-10.14.1 Material Contract HTML 56K 35: EX-10.15 Material Contract HTML 83K 36: EX-10.16 Material Contract HTML 52K 37: EX-10.16.1 Material Contract HTML 37K 38: EX-10.16.1.1 Material Contract HTML 20K 39: EX-10.16.2 Material Contract HTML 51K 40: EX-10.16.3 Material Contract HTML 278K 41: EX-10.17 Material Contract HTML 32K 42: EX-10.17.1 Material Contract HTML 51K 43: EX-10.17.2 Material Contract HTML 33K 44: EX-10.17.3 Material Contract HTML 54K 45: EX-10.18 Material Contract HTML 70K 46: EX-10.18.1 Material Contract HTML 41K 47: EX-10.18.2 Material Contract HTML 44K 48: EX-10.18.3 Material Contract HTML 35K 49: EX-10.18.4 Material Contract HTML 27K 50: EX-10.18.5 Material Contract HTML 26K 51: EX-10.18.6 Material Contract HTML 38K 52: EX-10.18.6.1 Material Contract HTML 37K 53: EX-10.18.6.2 Material Contract HTML 72K 54: EX-10.18.7 Material Contract HTML 51K 55: EX-10.19 Material Contract HTML 63K 56: EX-10.19.1 Material Contract HTML 35K 57: EX-10.19.2 Material Contract HTML 35K 58: EX-10.19.2.1 Material Contract HTML 36K 59: EX-10.19.3 Material Contract HTML 51K 60: EX-10.19.4 Material Contract HTML 20K 11: EX-10.2 Material Contract HTML 143K 12: EX-10.2.1 Material Contract HTML 26K 13: EX-10.2.2 Material Contract HTML 65K 14: EX-10.2.3 Material Contract HTML 43K 15: EX-10.2.4 Material Contract HTML 45K 16: EX-10.2.5 Material Contract HTML 41K 61: EX-10.20 Material Contract HTML 57K 62: EX-10.20.1 Material Contract HTML 35K 63: EX-10.20.2 Material Contract HTML 51K 64: EX-10.21 Material Contract HTML 38K 65: EX-10.21.1 Material Contract HTML 53K 66: EX-10.21.2 Material Contract HTML 29K 67: EX-10.22 Material Contract HTML 73K 68: EX-10.23 Material Contract HTML 60K 17: EX-10.3 Material Contract HTML 88K 18: EX-10.4 Material Contract HTML 68K 19: EX-10.5 Material Contract HTML 38K 20: EX-10.6 Material Contract HTML 105K 21: EX-10.7 Material Contract HTML 116K 22: EX-10.8 Material Contract HTML 124K 69: EX-21.1 Subsidiaries HTML 16K 70: EX-23.1 Consent of Experts or Counsel HTML 17K
| EX-10.19.2.1 |
Exhibit 10.19.2.1
NOTE CONVERSION AGREEMENT
THIS NOTE CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of [ ], 2013, by and between BIOCEPT, INC., a California corporation (the “Company”), and (the “Noteholder”).
RECITALS
WHEREAS, the Company and the Noteholder previously entered into that certain Note and Warrant Purchase Agreement, dated as of January 13, 2012, as amended, pursuant to which the Company issued and sold to the Noteholder the promissory notes set forth on SCHEDULE A hereto (each a “Note” and collectively, the “Notes”); and
WHEREAS, the Company and the Noteholder now desire to convert the entire unpaid principal and accrued interest outstanding under the Notes into shares of Series A Preferred Stock of the Company (“Series A Preferred”) on the terms and conditions set forth in this Agreement, and after such conversion, the Notes shall be cancelled.
NOW, THEREFORE, in contemplation of the foregoing and in consideration of the mutual agreements, covenants, representations and warranties contained herein, and for other valid consideration, the receipt and sufficiency of which the hereby acknowledged, and intending to be legally bound hereby, the parties agree as follows:
AGREEMENT
1. Conversion of Notes. Effective immediately, the entire unpaid principal and accrued interest outstanding under the Notes (the “Outstanding Balance”) shall be automatically converted into an aggregate of [ ] shares of Series A Preferred (the “Conversion Shares”). The parties hereto agree that upon such conversion of the Outstanding Balance, all amounts owed under the Notes shall be deemed paid in full, the Notes shall be terminated and cancelled in full, and no party shall have any further obligations or commitments with respect thereto except as expressly provided for under this Agreement. Promptly following the date hereof (i) the Noteholder agrees to return to the Company for cancellation the original Notes held by the Noteholder and (ii) the Company shall issue to the Noteholder the Conversion Shares. Other than the Noteholder’s right to receive the Conversion Shares, the Noteholder hereby waives any and all demands, claims, suits, actions, causes of action, proceedings, assessments and rights in respect of the Notes, including, without limitation, any rights arising from any default or event of default under the Notes.
2. Noteholder Representations. The Noteholder hereby represents and warrants to the Company as follows:
(a) The Noteholder is the sole beneficial owner of the Notes held by it as indicated on SCHEDULE A hereto and the Noteholder has not sold, assigned, transferred, endorsed, deposited under any agreement, hypothecated, pledged for any bank or brokerage loan or otherwise, or disposed of in any manner any such Note or any interest therein, other than in
connection with the cancellation of the Notes as contemplated herein.
(b) The Noteholder is acquiring the Conversion Shares solely for its own account for investment purposes only and not with a view to any sale or distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”). The Noteholder has no pre-existing agreement, arrangement or understanding, formal or informal, with any person to sell, distribute or transfer all or any part of such Conversion Shares.
(c) The Noteholder understands that (i) the Conversion Shares have not been registered under the Securities Act or any state securities law by reason of their issuance in a transaction which is exempt from the registration requirements of the Securities Act and state securities laws, and that such securities must be held indefinitely unless they are subsequently registered under the Securities Act and such laws or a subsequent disposition thereof is exempt from registration under the applicable provisions of the Securities Act and such laws and (ii) the certificates evidencing such securities will contain a legend to the foregoing effect.
(d) The Noteholder has sufficient knowledge and expertise in business and financial matters so as to enable it to analyze and evaluate the merits and risks of acquiring the Conversion Shares pursuant to the terms of this Agreement.
(e) The Noteholder is an accredited investor within the meaning of Regulation D under the Securities Act.
(f) The Noteholder has had an opportunity to discuss the Company’s business, management and financial affairs with directors, officers and management of the Company and has had the opportunity to review the Company’s operations and facilities. The Noteholder has also had the opportunity to ask questions of and receive answers from, the Company and its management regarding the terms and conditions of this investment.
(g) The Noteholder has the requisite power and authority to enter into this Agreement and to agree to the conversion of the Notes held by it under this Agreement.
3. Market Stand-Off Agreement. The Noteholder hereby agrees that the Noteholder shall not sell, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, any Common Stock (or other securities) of the Company held by the Noteholder (other than those included in the registration) during (i) the 180-day period following the effective date of the Company’s first firm commitment underwritten public offering of its Common Stock registered under the Securities Act (or such longer period as the underwriters or the Company shall request in order to facilitate compliance with NASD Rule 2711 or NYSE Member Rule 472 or any successor or similar rule or regulation), and (ii) the 90-day period following the effective date of a registration statement of the Company filed under the Securities Act (or such longer period as the underwriters or the Company shall request in order to facilitate compliance with NASD Rule 2711 or NYSE Member Rule 472 or any successor or similar rule or regulation); provided, that, with respect to (i) and (ii) above, all officers and directors of the Company are bound by and have entered into similar agreements. The obligations described in this Section 3 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar
2
forms that may be promulgated in the future, or a registration relating solely to a transaction on Form S-4 or similar forms that may be promulgated in the future.
4. Miscellaneous.
4.1 Governing Law. This Agreement shall be governed by and construed under the laws of the State of California in all respects as such laws are applied to agreements among California residents entered into and to be performed entirely within California, without reference to conflicts of laws or principles thereof. The parties agree that any action brought by either party under or in relation to this Agreement, including without limitation to interpret or enforce any provision of this Agreement, shall be brought in, and each party agrees to and does hereby submit to the jurisdiction and venue of, any state or federal court located in the County of San Diego, California.
4.2 Counterparts; Facsimile. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. Facsimile signatures shall be as effective as original signatures.
4.3 Further Assurances. Each party hereto agrees to execute and deliver, or cause to be executed and delivered, such further instruments or documents or take such other actions as may be reasonably necessary to consummate the transactions contemplated by this Agreement.
4.4 Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon the parties hereto and their respective successors, assigns, heirs, executors and administrators and shall inure to the benefit of and be enforceable by each person who shall be a holder of the Conversion Shares from time to time; provided, however, that prior to the receipt by the Company of adequate written notice of the transfer of any Conversion Shares specifying the full name and address of the transferee, the Company may deem and treat the person listed as the holder of such Conversion Shares in its records as the absolute owner and holder of such Conversion Shares for all purposes.
4.5 Severability. In the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein.
4.6 Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof and no party shall be liable or bound to any other in any manner by any representations, warranties, covenants and agreements except as specifically set forth herein.
3
IN WITNESS WHEREOF, the parties have executed this NOTE CONVERSION AGREEMENT as of the date first written above.
| COMPANY: | ||
| BIOCEPT, INC. | ||
| By: | ||
| Name: | ||
| Title: | ||
IN WITNESS WHEREOF, the parties have executed this NOTE CONVERSION AGREEMENT as of the date first written above.
| NOTEHOLDER: | ||
| By: | ||
| Name: | ||
| Title: | ||
SCHEDULE A
SCHEDULE OF NOTES
| NOTEHOLDER | TITLE | DATE ISSUED | PRINCIPAL AMOUNT | |||
| [________________] | Promissory Note | [_______] | $[_________] | |||
| [________________] | Promissory Note | [_______] | $[_________] |
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/23/13 | DRS | ||
| 1/13/12 | ||||
| List all Filings | ||||